+44 (0) 1223 755950             
                              +1 832 327 7413            
                    Orders to United States ship from United States
 (0 Publications and Reviews)
(0 Publications and Reviews)   
                  
                | Target | SARS-CoV-2 Spike Protein RBD (N450K Mutation) | 
| Research Area | Infection Immunity | 
| Target Modification | Asn450Lys | 
| Modification | Mutation | 
| Origin | Virus | 
| Expression | Recombinant | 
| Tested Applications | SDS-PAGE | 
| Host | HEK293 cells | 
| Recommended dilutions | Optimal dilutions/concentrations should be determined by the end user. | 
| Conjugation | Unconjugated | 
| Form | Lyophilized | 
| Purity | > 90% (SDS-PAGE) | 
| Reconstitution | Reconstitute in ddH2O to a concentration of 1 mg/ml. | 
| Storage | Store between -20°C and -80°C. Avoid repeated freeze/thaw cycles. | 
| NCBI Accession | YP_009724390.1 | 
| Molecular Weight | Observed MW: 35 kDa | 
| Tag | C-terminal His tag | 
| Buffer | Prior to lyophilization: PBS, pH 7.5. | 
| Availability | Shipped within 5-10 working days. | 
| Note | THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION. |